Fundraising Fox

Objective Biotechnology

Minneapolis, US · Founded 2023 · Delaware corporation

Objective Biotechnology develops neurotechnology tools for cortex-wide optical access and neural recordings in unrestrained rodent models, along with automated microinjection systems for large-scale genetic manipulation and embryo microinjection. Its products serve researchers working with biological systems.

Founders & leadership

JG
James GrabauCEO
DS
Daniel SurinachNamed on SEC filing
AJ
Amey JoshiNamed on SEC filing
SK
Suhasa KodandaramaiahCTO
AA
Andrew AlegriaNamed on SEC filing
DG
Daryl GohlCSO

Reported raises · per SEC filings

Form D private placements

$715K disclosed across 1 round · 2024

$715KraisedNov 2024 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James GrabauExecutive Officer
  • Daniel SurinachExecutive Officer, Director
  • Amey JoshiExecutive Officer, Director
  • Suhasa KodandaramaiahExecutive Officer, Director
  • Andrew AlegriaExecutive Officer, Director
  • Daryl GohlExecutive Officer, Director
Offering amount
$1M
Amount sold
$715K
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Objective Biotechnology for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Objective Biotechnology do?
Objective Biotechnology develops neurotechnology tools for cortex-wide optical access and neural recordings in unrestrained rodent models, along with automated microinjection systems for large-scale genetic manipulation and embryo microinjection. Its products serve researchers working with biological systems.
How much funding has Objective Biotechnology raised?
Objective Biotechnology has disclosed $715K raised across 1 round.
Where is Objective Biotechnology headquartered?
Objective Biotechnology is headquartered in Minneapolis, US.